vimarsana.com
Home
Live Updates
Defining Meaningful Outcomes In Gene Therapy Trials For Duchenne Muscular Dystrophy : vimarsana.com
Defining Meaningful Outcomes In Gene Therapy Trials For Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD), the most common form of muscular dystrophy, is an X-linked recessive disease that affects approximately one in...
Related Keywords
Switzerland
,
Romania
,
Roxana Donisa Dreghici
,
Patrick Gonzalez
,
Carl Morris
,
Carla Morris
,
J Patrick Gonzalez
,
Dalle Pazze
,
University Of Medicine
,
Franklin Pierce College
,
Syracuse University
,
Boston University School Of Medicine
,
Novartis
,
Department Of Physiology
,
Research Unit
,
Pfizer Rare Disease Research Unit
,
Rutgers University
,
European Medicines Agency
,
University Of Pennsylvania
,
Mcdonald
,
Novo Nordisk
,
Morris
,
Solid Biosciences
,
North Star Ambulatory Assessment
,
Upper Limb
,
Solid Bioscience Phase
,
Pediatric Outcomes Data Collection Instrument
,
Duchenne Video Assessment
,
Chief Scientific Officer
,
Rare Disease Research Unit
,
Boston University School
,
Aging Research
,
Donisa Dreghici
,
vimarsana.com © 2020. All Rights Reserved.